Author details

Full Name

Rafal Kaminski

Affiliation

ORCID

Career Start Year

2006

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37126704	CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice.		2023
37587230	Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates.		2023
37346975	Strategic self-limiting production of infectious HIV particles by CRISPR in permissive cells.		2023
33278736	Human neurotropic polyomavirus, JC virus, agnoprotein targets mitochondrion and modulates its functions.	Virology	2021
34033077	Isolation and Propagation of Primary Human and Rodent Embryonic Neural Progenitor Cells and Cortical Neurons.	Methods in Molecular Biology	2021
33247091	CRISPR based editing of SIV proviral DNA in ART treated non-human primates.	Nature Communications	2020
32117811	Amplification of Replication Competent HIV-1 by Adoptive Transfer of Human Cells From Infected Humanized Mice.	Frontiers in Cellular and Infection Microbiology	2020
31266936	Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice.	Nature Communications	2019
30195766	Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice.	Molecular Therapy - Nucleic Acids	2018
27249540	Non-Metabolic Role of PKM2 in Regulation of the HIV-1 LTR.	Journal of Cellular Physiology	2017
28819214	HIV-1 Nef-induced cardiotoxicity through dysregulation of autophagy.	Scientific Reports	2017
28460414	CRISPR Editing Technology in Biological and Biomedical Investigation.	Journal of Cellular Biochemistry	2017
27528385	Negative Feedback Regulation of HIV-1 by Gene Editing Strategy.	Scientific Reports	2016
27389633	Corrigendum: Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing.	Scientific Reports	2016
27194423	Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study.	Gene Therapy	2016
27150390	Gene Editing for Treatment of Neurological Infections.		2016
27009094	HIV-1 Latency and Eradication: Past, Present and Future.	Curr HIV Res	2016
27488023	Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study.	Gene Therapy	2016
26939770	Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing.	Scientific Reports	2016
26538064	CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs.	Scientific Reports	2015
25602755	Role of hexokinase-1 in the survival of HIV-1-infected macrophages.	Cell Cycle	2015
25716921	Genome editing strategies: potential tools for eradicating HIV-1/AIDS.	Journal of NeuroVirology	2015
26360417	CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection.	PLoS ONE	2015
24847939	Interplay of Rad51 with NF-ÎºB pathway stimulates expression of HIV-1.	PLoS ONE	2014
25310191	Rad51 activates polyomavirus JC early transcription.	PLoS ONE	2014
25049410	RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.	Proceedings of the National Academy of Sciences of the United States of America	2014
23086711	Polyomavirus JC infection inhibits differentiation of oligodendrocyte progenitor cells.	Journal of Neuroscience Research	2013
23975820	Isolation and propagation of primary human and rodent embryonic neural progenitor cells and cortical neurons.	Methods in Molecular Biology	2013
22034072	JCV agnoprotein-induced reduction in CXCL5/LIX secretion by oligodendrocytes is associated with activation of apoptotic signaling in neurons.	Journal of Cellular Physiology	2012
22427948	The level of DING proteins is increased in HIV-infected patients: in vitro and in vivo studies.	PLoS ONE	2012
20948313	Role of PurÎ± in the cellular response to ultraviolet-C radiation.	Cell Cycle	2010
19282432	Evidence for modulation of BAG3 by polyomavirus JC early protein.	Journal of General Virology	2009
18630497	Role of Puralpha in the modulation of homologous recombination-directed DNA repair by HIV-1 Tat.	Anticancer Research	2008
17989177	JC virus agnoprotein inhibits in vitro differentiation of oligodendrocytes and promotes apoptosis.	Journal of Virology	2008
17722108	Puralpha as a cellular co-factor of Rev/RRE-mediated expression of HIV-1 intron-containing mRNA.	Journal of Cellular Biochemistry	2008
18927497	Protective role of Puralpha to cisplatin.	Cancer Biology and Therapy	2008
16940540	Cross-interaction between JC virus agnoprotein and human immunodeficiency virus type 1 (HIV-1) Tat modulates transcription of the HIV-1 long terminal repeat in glial cells.	Journal of Virology	2006